Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05839873 · ClinicalTrials.gov registry record

Abbott Ventricular Tachycardia PAS

A clinical trial of Ventricular Tachycardia, sponsored by Abbott Medical Devices.

Active
Registry status
62
Enrollment target
11
Study locations

NCT05839873 is a study of Ventricular Tachycardia that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 62 participants, below the 286-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (78% lower). The trial reports 11 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05839873, a study of Ventricular Tachycardia, is active but no longer recruiting, sponsored by Abbott Medical Devices.

ACTIVE NOT RECRUITING
Registry status
62 participants
Enrollment target
11
Study locations

Study Summary

This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.

Conditions Studied

Ventricular Tachycardia

Interventions

  • DEVICE FlexAbility SE Ablation Catheter

Study Locations (11)

Florida

  • NCH Healthcare System - Naples

Indiana

  • St. Vincent Hospital - Indianapolis

Kansas

  • Kansas City Cardiac Arrhythmia Research Foundation - Overland Park

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • VA Medical Center Minneapolis - Minneapolis

North Carolina

  • Carolinas Medical Center - Charlotte

Oklahoma

  • Integris Baptist Medical Center - Oklahoma City

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2023-07-24
Est. Completion 2026-11

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05839873

The ClinicalTrials.gov registry entry for NCT05839873 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (78% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which FlexAbility SE Ablation Catheter is the first listed.

NCT05839873 reports 11 study locations spanning 11 distinct geographic areas - top geographies include Florida, Indiana, Kansas.

Frequently Asked Questions

What is clinical trial NCT05839873 about?

NCT05839873 is a clinical study titled "Abbott Ventricular Tachycardia PAS". This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospecti...

What is the current status of trial NCT05839873?

This trial is currently active not recruiting. The enrollment target is 62 participants. The study started on 2023-07-24. Estimated completion is 2026-11.

What conditions does trial NCT05839873 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT05839873?

The interventions under investigation include: FlexAbility SE Ablation Catheter (DEVICE).

Who is sponsoring clinical trial NCT05839873?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05839873 being conducted?

This trial has 11 study locations across Florida, Indiana, Kansas, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventricular Tachycardia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.